BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

220 related articles for article (PubMed ID: 17293884)

  • 1. PTEN, the Achilles' heel of myocardial ischaemia/reperfusion injury?
    Mocanu MM; Yellon DM
    Br J Pharmacol; 2007 Apr; 150(7):833-8. PubMed ID: 17293884
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Selective inhibition of PTEN preserves ischaemic post-conditioning cardioprotection in STZ-induced Type 1 diabetic rats: role of the PI3K/Akt and JAK2/STAT3 pathways.
    Xue R; Lei S; Xia ZY; Wu Y; Meng Q; Zhan L; Su W; Liu H; Xu J; Liu Z; Zhou B; Xia Z
    Clin Sci (Lond); 2016 Mar; 130(5):377-92. PubMed ID: 26666444
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Kinases and phosphatases in ischaemic preconditioning: a re-evaluation.
    Fan WJ; van Vuuren D; Genade S; Lochner A
    Basic Res Cardiol; 2010 Jul; 105(4):495-511. PubMed ID: 20127248
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Ischemia-reperfusion injury and cardioprotection: investigating PTEN, the phosphatase that negatively regulates PI3K, using a congenital model of PTEN haploinsufficiency.
    Siddall HK; Warrell CE; Yellon DM; Mocanu MM
    Basic Res Cardiol; 2008 Nov; 103(6):560-8. PubMed ID: 18604624
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Variable activation of phosphoinositide 3-kinase influences the response of liver grafts to ischemic preconditioning.
    Cescon M; Carini R; Grazi G; Caraceni P; Alchera E; Gasloli G; Ravaioli M; Tuci F; Imarisio C; Dal Ponte C; Pertosa AM; Bernardi M; Pinna AD; Albano E
    J Hepatol; 2009 May; 50(5):937-47. PubMed ID: 19303157
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Role of PI3K in myocardial ischaemic preconditioning: mapping pro-survival cascades at the trigger phase and at reperfusion.
    Rossello X; Riquelme JA; Davidson SM; Yellon DM
    J Cell Mol Med; 2018 Feb; 22(2):926-935. PubMed ID: 29159980
    [TBL] [Abstract][Full Text] [Related]  

  • 7. New directions for protecting the heart against ischaemia-reperfusion injury: targeting the Reperfusion Injury Salvage Kinase (RISK)-pathway.
    Hausenloy DJ; Yellon DM
    Cardiovasc Res; 2004 Feb; 61(3):448-60. PubMed ID: 14962476
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Impacts of delta 9-tetrahydrocannabinol against myocardial ischemia/reperfusion injury in diabetic rats: Role of PTEN/PI3K/Akt signaling pathway.
    Zhao X; Gao Z; Wen W; Zheng S
    Chin J Physiol; 2023; 66(6):446-455. PubMed ID: 38149557
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Ischemic postconditioning protects remodeled myocardium via the PI3K-PKB/Akt reperfusion injury salvage kinase pathway.
    Zhu M; Feng J; Lucchinetti E; Fischer G; Xu L; Pedrazzini T; Schaub MC; Zaugg M
    Cardiovasc Res; 2006 Oct; 72(1):152-62. PubMed ID: 16901477
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effects of hydrogen sulphide on ischaemia-reperfusion injury and ischaemic preconditioning in the isolated, perfused rat heart.
    Bliksøen M; Kaljusto ML; Vaage J; Stensløkken KO
    Eur J Cardiothorac Surg; 2008 Aug; 34(2):344-9. PubMed ID: 18455926
    [TBL] [Abstract][Full Text] [Related]  

  • 11. (‑)‑Epicatechin protects against myocardial ischemia‑induced cardiac injury via activation of the PTEN/PI3K/AKT pathway.
    Li JW; Wang XY; Zhang X; Gao L; Wang LF; Yin XH
    Mol Med Rep; 2018 Jun; 17(6):8300-8308. PubMed ID: 29658565
    [TBL] [Abstract][Full Text] [Related]  

  • 12. PPAR-alpha activation as a preconditioning-like intervention in rats in vivo confers myocardial protection against acute ischaemia-reperfusion injury: involvement of PI3K-Akt.
    Ravingerová T; Carnická S; Nemčeková M; Ledvényiová V; Adameová A; Kelly T; Barlaka E; Galatou E; Khandelwal VK; Lazou A
    Can J Physiol Pharmacol; 2012 Aug; 90(8):1135-44. PubMed ID: 22809038
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Desmethylanhydroicaritin inhibits NF-kappaB-regulated inflammatory gene expression by modulating the redox-sensitive PI3K/PTEN/Akt pathway.
    Kim JH; Lee G; Cho YL; Kim CK; Han S; Lee H; Choi JS; Choe J; Won MH; Kwon YG; Ha KS; Kim YM
    Eur J Pharmacol; 2009 Jan; 602(2-3):422-31. PubMed ID: 19027002
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Pharmacological preconditioning with tumor necrosis factor-alpha activates signal transducer and activator of transcription-3 at reperfusion without involving classic prosurvival kinases (Akt and extracellular signal-regulated kinase).
    Lecour S; Suleman N; Deuchar GA; Somers S; Lacerda L; Huisamen B; Opie LH
    Circulation; 2005 Dec; 112(25):3911-8. PubMed ID: 16344382
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Mitochondrial KATP opening confers protection against lethal myocardial injury and ischaemia-induced arrhythmias in the rat heart via PI3K/Akt-dependent and -independent mechanisms.
    Matejíková J; Ravingerová T; Pancza D; Carnická S; Kolár F
    Can J Physiol Pharmacol; 2009 Dec; 87(12):1055-62. PubMed ID: 20029542
    [TBL] [Abstract][Full Text] [Related]  

  • 16. microRNA-21 protects against ischemia-reperfusion and hypoxia-reperfusion-induced cardiocyte apoptosis via the phosphatase and tensin homolog/Akt-dependent mechanism.
    Yang Q; Yang K; Li A
    Mol Med Rep; 2014 Jun; 9(6):2213-20. PubMed ID: 24676391
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Complete loss of ischaemic preconditioning-induced cardioprotection in mice with partial deficiency of HIF-1 alpha.
    Cai Z; Zhong H; Bosch-Marce M; Fox-Talbot K; Wang L; Wei C; Trush MA; Semenza GL
    Cardiovasc Res; 2008 Feb; 77(3):463-70. PubMed ID: 18006459
    [TBL] [Abstract][Full Text] [Related]  

  • 18. PTEN activity is modulated during ischemia and reperfusion: involvement in the induction and decay of preconditioning.
    Cai Z; Semenza GL
    Circ Res; 2005 Dec; 97(12):1351-9. PubMed ID: 16284183
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Rosiglitazone-induced myocardial protection against ischaemia-reperfusion injury is mediated via a phosphatidylinositol 3-kinase/Akt-dependent pathway.
    Zhang XJ; Xiong ZB; Tang AL; Ma H; Ma YD; Wu JG; Dong YG
    Clin Exp Pharmacol Physiol; 2010 Feb; 37(2):156-61. PubMed ID: 19566839
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Enhancement of DC vaccine potency by activating the PI3K/AKT pathway with a small interfering RNA targeting PTEN.
    Kim JH; Kang TH; Noh KH; Kim SH; Lee YH; Kim KW; Bae HC; Ahn YH; Choi EY; Kim JS; Lee KM; Kim TW
    Immunol Lett; 2010 Nov; 134(1):47-54. PubMed ID: 20727912
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.